In this Concise Practice Point, we critically appraise published evidence to produce evidence-based recommendations on Intraoperative Antimicrobial Prophylaxis in Elective Cataract Surgery Patients.
This document provides advice to clinicains on referring suspected ocular oncology cases to the nationally designated ocular oncology centres.
These guidelines cover primary angle-closure only and specifically excludes secondary disease such as that resulting from uveitis or neovascularization. It is primarily for clinicians involved in eye care in the community and in hospital eye services and aims to inform clinicians. 1. What is the accuracy of current diagnostic tests 2. What is the effectiveness of different interventions 3. When to refer to hospital eye services 4. When to discharge to community Executive Summary
Summarises existing guidelines to show how currently available training and qualifications enable Health Care Professionals (HCPs) to deliver care for patients with different categories of GLAUC-STRAT-FAST risk.
This guideline covers the screening and treatment of reinopathy of prematurity. Retinopathy of prematurity (ROP) is a potentially blinding condition affecting low gestation and very low birth weight infants. Worldwide it is a major cause of preventable blindness. Screening for ROP is undertaken to identify ROP that requires treatment. This evidence-based guideline for the treatment of ROP was developed by a guideline development group (GDG) of The Royal College of Ophthalmologists (RCOphth), the UK special interest group of ROP screeners and treaters (ROP-SIG) and the charity Bliss. The guideline was produced according to RCOphth standards for guideline development.
This document is targeted at surgeons and health care professionals involved in the care of patients undergoing refractive surgery. We emphasise throughout that surgeons are ultimately responsible for the safe delivery of patient care.
This guideline update includes responses to the consultation in October 2021. It incorporates the impact of new imaging modalities and their findings on the management of retinal vein occlusion. The use of intravitreal agents in the management of retinal vein occlusion has been updated to reflect the increasing body of literature on its use along with the impact this treatment has on the natural history and complications of retinal vein occlusion. Scope: diagnostic tools, management, service set up and delivery of optimal care pathway for patients with RVO.
The aim of this document is to provide advice on the identification and management of an outbreak of post ophthalmic procedure (post-op) endophthalmitis. The guidance will concentrate particularly on cataract surgery, but the principles and much of the detail are applicable to other intraocular procedures including intravitreal injections.
This paper produced by SeeAbility, the Association of British Dispensing Opticians, the British and Irish Orthoptic Society, the College of Optometrists, the Local Optical Committee Support Unit (LOCSU) and the Royal College of Ophthalmologists, supported with advice from the Children’s Vision Service Advisory Group in Wales, provides a framework whereby all children and young people in special schools in England gain equitable access to regular eye care